Announcements
- EUROBIO SCIENTIFIC : CALENDRIER DES PUBLICATIONS FINANCIÈRES DU 2EME SEMESTRE
- Eurobio Scientific : bilan semestriel du contrat de liquidité
- EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER ENDOPREDICT®
- EUROBIO SCIENTIFIC SIGNE UN ACCORD POUR L'ACQUISITION DU TEST D'EXPRESSION GÉNIQUE POUR LE CANCER DU SEIN ENDOPREDICT®
- Eurobio Scientific : mise à disposition du rapport financier annuel 2023
- Eurobio Scientific : Rapport Financier Annuel 2023
- EUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS
- EUROBIO SCIENTIFIC: RESULTAT ANNUEL 2023
- Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP
- Eurobio Scientific : EXERCICE 2023, CONFIRMATION DE LA TRANSFORMATION STRATEGIQUE
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 2.40 |
Average volume | -- |
---|---|
Shares outstanding | 10.25m |
Free float | 5.01m |
P/E (TTM) | 38.80 |
Market cap | 171.57m EUR |
EPS (TTM) | 0.4315 EUR |
Data delayed at least 15 minutes.
More ▼